1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neutropenia Biologic Drug Treatment Consumption 2015-2025

2.1.2 Neutropenia Biologic Drug Treatment Consumption CAGR by Region

2.2 Neutropenia Biologic Drug Treatment Segment by Drug Type

2.2.1 Filgrastim

2.2.2 Pegfilgrastim

2.2.3 Lenograstim

2.2.4 Lipegfilgrastim

2.2.5 Sargramostim

2.3 Neutropenia Biologic Drug Treatment Consumption by Drug Type

2.3.1 Global Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

2.3.2 Global Neutropenia Biologic Drug Treatment Revenue and Market Share by Drug Type (2015-2020)

2.3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Drug Type (2015-2020)

2.4 Neutropenia Biologic Drug Treatment Segment by Application

2.4.1 Retail Pharmacies

2.4.2 Hospital Pharmacies

2.4.3 Online Pharmacies

2.5 Neutropenia Biologic Drug Treatment Consumption by Application

2.5.1 Global Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

2.5.2 Global Neutropenia Biologic Drug Treatment Value and Market Share by Drug Type (2015-2020)

2.5.3 Global Neutropenia Biologic Drug Treatment Sale Price by Drug Type (2015-2020)

3 Global Neutropenia Biologic Drug Treatment by Company

3.1 Global Neutropenia Biologic Drug Treatment Sales Market Share by Company

3.1.1 Global Neutropenia Biologic Drug Treatment Sales by Company (2018-2020)

3.1.2 Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2018-2020)

3.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company

3.2.1 Global Neutropenia Biologic Drug Treatment Revenue by Company (2018-2020)

3.2.2 Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2018-2020)

3.3 Global Neutropenia Biologic Drug Treatment Sale Price by Company

3.4 Global Neutropenia Biologic Drug Treatment Manufacturing Base Distribution, Sales Area, Drug Type by Company

3.4.1 Global Neutropenia Biologic Drug Treatment Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Neutropenia Biologic Drug Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Neutropenia Biologic Drug Treatment by Regions

4.1 Neutropenia Biologic Drug Treatment by Regions

4.2 Americas Neutropenia Biologic Drug Treatment Consumption Growth

4.3 APAC Neutropenia Biologic Drug Treatment Consumption Growth

4.4 Europe Neutropenia Biologic Drug Treatment Consumption Growth

4.5 Middle East & Africa Neutropenia Biologic Drug Treatment Consumption Growth

5 Americas

5.1 Americas Neutropenia Biologic Drug Treatment Consumption by Countries

5.1.1 Americas Neutropenia Biologic Drug Treatment Consumption by Countries (2015-2020)

5.1.2 Americas Neutropenia Biologic Drug Treatment Value by Countries (2015-2020)

5.2 Americas Neutropenia Biologic Drug Treatment Consumption by Drug Type

5.3 Americas Neutropenia Biologic Drug Treatment Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Neutropenia Biologic Drug Treatment Consumption by Regions

6.1.1 APAC Neutropenia Biologic Drug Treatment Consumption by Regions (2015-2020)

6.1.2 APAC Neutropenia Biologic Drug Treatment Value by Regions (2015-2020)

6.2 APAC Neutropenia Biologic Drug Treatment Consumption by Drug Type

6.3 APAC Neutropenia Biologic Drug Treatment Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Neutropenia Biologic Drug Treatment by Countries

7.1.1 Europe Neutropenia Biologic Drug Treatment Consumption by Countries (2015-2020)

7.1.2 Europe Neutropenia Biologic Drug Treatment Value by Countries (2015-2020)

7.2 Europe Neutropenia Biologic Drug Treatment Consumption by Drug Type

7.3 Europe Neutropenia Biologic Drug Treatment Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Neutropenia Biologic Drug Treatment by Countries

8.1.1 Middle East & Africa Neutropenia Biologic Drug Treatment Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Neutropenia Biologic Drug Treatment Value by Countries (2015-2020)

8.2 Middle East & Africa Neutropenia Biologic Drug Treatment Consumption by Drug Type

8.3 Middle East & Africa Neutropenia Biologic Drug Treatment Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Neutropenia Biologic Drug Treatment Distributors

10.3 Neutropenia Biologic Drug Treatment Customer

11 Global Neutropenia Biologic Drug Treatment Market Forecast

11.1 Global Neutropenia Biologic Drug Treatment Consumption Forecast (2021-2025)

11.2 Global Neutropenia Biologic Drug Treatment Forecast by Regions

11.2.1 Global Neutropenia Biologic Drug Treatment Forecast by Regions (2021-2025)

11.2.2 Global Neutropenia Biologic Drug Treatment Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast byRegions

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Neutropenia Biologic Drug Treatment Forecast by Drug Type

11.8 Global Neutropenia Biologic Drug Treatment Forecast by Application

12 Key Players Analysis

12.1 Amgen

12.1.1 Company Information

12.1.2 Neutropenia Biologic Drug Treatment Product Offered

12.1.3 Amgen Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Amgen Latest Developments

12.2 Kyowa Kirin

12.2.1 Company Information

12.2.2 Neutropenia Biologic Drug Treatment Product Offered

12.2.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Kyowa Kirin Latest Developments

12.3 Novartis

12.3.1 Company Information

12.3.2 Neutropenia Biologic Drug Treatment Product Offered

12.3.3 Novartis Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Novartis Latest Developments

12.4 Baxter International

12.4.1 Company Information

12.4.2 Neutropenia Biologic Drug Treatment Product Offered

12.4.3 Baxter International Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Baxter International Latest Developments

12.5 Cellerant Therapeutics

12.5.1 Company Information

12.5.2 Neutropenia Biologic Drug Treatment Product Offered

12.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Cellerant Therapeutics Latest Developments

12.6 Pfizer

12.6.1 Company Information

12.6.2 Neutropenia Biologic Drug Treatment Product Offered

12.6.3 Pfizer Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Pfizer Latest Developments

12.7 Sanofi

12.7.1 Company Information

12.7.2 Neutropenia Biologic Drug Treatment Product Offered

12.7.3 Sanofi Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Sanofi Latest Developments

12.8 Dong-A ST Co.,Ltd.

12.8.1 Company Information

12.8.2 Neutropenia Biologic Drug Treatment Product Offered

12.8.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Dong-A ST Co.,Ltd. Latest Developments

12.9 Teva Pharmaceutical Industries Ltd.

12.9.1 Company Information

12.9.2 Neutropenia Biologic Drug Treatment Product Offered

12.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Teva Pharmaceutical Industries Ltd. Latest Developments

12.10 Myelo Therapeutics GmbH

12.10.1 Company Information

12.10.2 Neutropenia Biologic Drug Treatment Product Offered

12.10.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Myelo Therapeutics GmbH Latest Developments

12.11 CVS Health

12.11.1 Company Information

12.11.2 Neutropenia Biologic Drug Treatment Product Offered

12.11.3 CVS Health Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 CVS Health Latest Developments

12.12 Enzychem Lifesciences Corporation

12.12.1 Company Information

12.12.2 Neutropenia Biologic Drug Treatment Product Offered

12.12.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 Enzychem Lifesciences Corporation Latest Developments

12.13 Partner Therapeutics

12.13.1 Company Information

12.13.2 Neutropenia Biologic Drug Treatment Product Offered

12.13.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Partner Therapeutics Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Neutropenia Biologic Drug Treatment Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Filgrastim

Table 5. Major Players of Pegfilgrastim

Table 6. Major Players of Lenograstim

Table 7. Major Players of Lipegfilgrastim

Table 8. Major Players of Sargramostim

Table 9. Global Consumption Sales by Drug Type (2015-2020)

Table 10. Global Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

Table 11. Global Neutropenia Biologic Drug Treatment Revenue by Drug Type (2015-2020) ($ million)

Table 12. Global Neutropenia Biologic Drug Treatment Value Market Share by Drug Type (2015-2020) ($ Millions)

Table 13. Global Neutropenia Biologic Drug Treatment Sale Price by Drug Type (2015-2020)

Table 14. Global Consumption Sales by Application (2015-2020)

Table 15. Global Neutropenia Biologic Drug Treatment Consumption Market Share by Application (2015-2020)

Table 16. Global Neutropenia Biologic Drug Treatment Value by Application (2015-2020)

Table 17. Global Neutropenia Biologic Drug Treatment Value Market Share by Application (2015-2020)

Table 18. Global Neutropenia Biologic Drug Treatment Sale Price by Application (2015-2020)

Table 19. Global Neutropenia Biologic Drug Treatment Sales by Company (2017-2019) (K Units)

Table 20. Global Neutropenia Biologic Drug Treatment Sales Market Share by Company (2017-2019)

Table 21. Global Neutropenia Biologic Drug Treatment Revenue by Company (2017-2019) ($ Millions)

Table 22. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company (2017-2019)

Table 23. Global Neutropenia Biologic Drug Treatment Sale Price by Company (2017-2019)

Table 24. Global Neutropenia Biologic Drug Treatment Manufacturing Base Distribution and Sales Area by Manufacturers

Table 25. Players Neutropenia Biologic Drug Treatment Products Offered

Table 26. Neutropenia Biologic Drug Treatment Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 27. Global Neutropenia Biologic Drug Treatment Consumption by Regions 2015-2020 (K Units)

Table 28. Global Neutropenia Biologic Drug Treatment Consumption Market Share by Regions 2015-2020

Table 29. Global Neutropenia Biologic Drug Treatment Value by Regions 2015-2020 ($ Millions)

Table 30. Global Neutropenia Biologic Drug Treatment Value Market Share by Regions 2015-2020

Table 31. Americas Neutropenia Biologic Drug Treatment Consumption by Countries (2015-2020) (K Units)

Table 32. Americas Neutropenia Biologic Drug Treatment Consumption Market Share by Countries (2015-2020)

Table 33. Americas Neutropenia Biologic Drug Treatment Value by Countries (2015-2020) ($ Millions)

Table 34. Americas Neutropenia Biologic Drug Treatment Value Market Share by Countries (2015-2020)

Table 35. Americas Neutropenia Biologic Drug Treatment Consumption by Type (2015-2020) (K Units)

Table 36. Americas Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

Table 37. Americas Neutropenia Biologic Drug Treatment Consumption by Application (2015-2020) (K Units)

Table 38. Americas Neutropenia Biologic Drug Treatment Consumption Market Share by Application (2015-2020)

Table 39. APAC Neutropenia Biologic Drug Treatment Consumption by Regions (2015-2020) (K Units)

Table 40. APAC Neutropenia Biologic Drug Treatment Consumption Market Share by Regions (2015-2020)

Table 41. APAC Neutropenia Biologic Drug Treatment Value by Regions (2015-2020) ($ Millions)

Table 42. APAC Neutropenia Biologic Drug Treatment Value Market Share by Regions (2015-2020)

Table 43. APAC Neutropenia Biologic Drug Treatment Consumption by Drug Type (2015-2020) (K Units)

Table 44. APAC Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

Table 45. APAC Neutropenia Biologic Drug Treatment Consumption by Application (2015-2020) (K Units)

Table 46. APAC Neutropenia Biologic Drug Treatment Consumption Market Share by Application (2015-2020)

Table 47. Europe Neutropenia Biologic Drug Treatment Consumption by Countries (2015-2020) (K Units)

Table 48. Europe Neutropenia Biologic Drug Treatment Consumption Market Share by Countries (2015-2020)

Table 49. Europe Neutropenia Biologic Drug Treatment Value by Countries (2015-2020) ($ Millions)

Table 50. Europe Neutropenia Biologic Drug Treatment Value Market Share by Countries (2015-2020)

Table 51. Europe Neutropenia Biologic Drug Treatment Consumption by Type (2015-2020) (K Units)

Table 52. Europe Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

Table 53. Europe Neutropenia Biologic Drug Treatment Consumption by Application (2015-2020) (K Units)

Table 54. Europe Neutropenia Biologic Drug Treatment Consumption Market Share by Application (2015-2020)

Table 55. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption by Countries (2015-2020) (K Units)

Table 56. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Neutropenia Biologic Drug Treatment Value by Countries (2015-2020) ($ Millions)

Table 58. Middle East & Africa Neutropenia Biologic Drug Treatment Value Market Share by Countries (2015-2020)

Table 59. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption by Drug Type (2015-2020) (K Units)

Table 60. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

Table 61. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption by Application (2015-2020) (K Units)

Table 62. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption Market Share by Application (2015-2020)

Table 63. Neutropenia Biologic Drug Treatment Distributors List

Table 64. Neutropenia Biologic Drug Treatment Customer List

Table 65. Global Neutropenia Biologic Drug Treatment Consumption Forecast by Countries (2021-2025) (K Units)

Table 66. Global Neutropenia Biologic Drug Treatment Consumption Market Forecast by Regions

Table 67. Global Neutropenia Biologic Drug Treatment Value Forecast by Countries (2021-2025) ($ Millions)

Table 68. Global Neutropenia Biologic Drug Treatment Value Market Share Forecast by Regions

Table 69. Global Neutropenia Biologic Drug Treatment Consumption Forecast by Drug Type (2021-2025) (K Units)

Table 70. Global Neutropenia Biologic Drug Treatment Consumption Market Share Forecast by Drug Type (2021-2025)

Table 71. Global Neutropenia Biologic Drug Treatment Value Forecast by Drug Type (2021-2025) ($ Millions)

Table 72. Global Neutropenia Biologic Drug Treatment Value Market Share Forecast by Drug Type (2021-2025)

Table 73. Global Neutropenia Biologic Drug Treatment Consumption Forecast by Application (2021-2025) (K Units)

Table 74. Global Neutropenia Biologic Drug Treatment Consumption Market Share Forecast by Application (2021-2025)

Table 75. Global Neutropenia Biologic Drug Treatment Value Forecast by Application (2021-2025) ($ Millions)

Table 76. Global Neutropenia Biologic Drug Treatment Value Market Share Forecast by Application (2021-2025)

Table 77. Amgen Product Offered

Table 78. Amgen Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 79. Amgen Main Business

Table 80. Amgen Latest Developments

Table 81. Amgen Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 82. Kyowa Kirin Product Offered

Table 83. Kyowa Kirin Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 84. Kyowa Kirin Main Business

Table 85. Kyowa Kirin Latest Developments

Table 86. Kyowa Kirin Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 87. Novartis Product Offered

Table 88. Novartis Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 89. Novartis Main Business

Table 90. Novartis Latest Developments

Table 91. Novartis Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 92. Baxter International Product Offered

Table 93. Baxter International Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 94. Baxter International Main Business

Table 95. Baxter International Latest Developments

Table 96. Baxter International Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 97. Cellerant Therapeutics Product Offered

Table 98. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 99. Cellerant Therapeutics Main Business

Table 100. Cellerant Therapeutics Latest Developments

Table 101. Cellerant Therapeutics Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 102. Pfizer Product Offered

Table 103. Pfizer Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 104. Pfizer Main Business

Table 105. Pfizer Latest Developments

Table 106. Pfizer Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 107. Sanofi Product Offered

Table 108. Sanofi Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 109. Sanofi Main Business

Table 110. Sanofi Latest Developments

Table 111. Sanofi Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 112. Dong-A ST Co.,Ltd. Product Offered

Table 113. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 114. Dong-A ST Co.,Ltd. Main Business

Table 115. Dong-A ST Co.,Ltd. Latest Developments

Table 116. Dong-A ST Co.,Ltd. Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 117. Teva Pharmaceutical Industries Ltd. Product Offered

Table 118. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 119. Teva Pharmaceutical Industries Ltd. Main Business

Table 120. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 121. Teva Pharmaceutical Industries Ltd. Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 122. Myelo Therapeutics GmbH Product Offered

Table 123. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 124. Myelo Therapeutics GmbH Main Business

Table 125. Myelo Therapeutics GmbH Latest Developments

Table 126. Myelo Therapeutics GmbH Basic Information, Company Total Revenue (in $ million), Neutropenia Biologic Drug Treatment Manufacturing Base, Sales Area and Its Competitors

Table 127. CVS Health Product Offered

Table 128. CVS Health Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 129. CVS Health Main Business

Table 130. CVS Health Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 131. CVS Health Latest Developments

Table 132. Enzychem Lifesciences Corporation Product Offered

Table 133. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 134. Enzychem Lifesciences Corporation Main Business

Table 135. Enzychem Lifesciences Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 136. Enzychem Lifesciences Corporation Latest Developments

Table 137. Partner Therapeutics Product Offered

Table 138. Partner Therapeutics Neutropenia Biologic Drug Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 139. Partner Therapeutics Main Business

Table 140. Partner Therapeutics Latest Developments

Table 141. Partner Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Neutropenia Biologic Drug Treatment

Figure 2. Neutropenia Biologic Drug Treatment Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Neutropenia Biologic Drug Treatment Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Neutropenia Biologic Drug Treatment Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Filgrastim

Figure 7. Product Picture of Pegfilgrastim

Figure 8. Product Picture of Lenograstim

Figure 9. Product Picture of Lipegfilgrastim

Figure 10. Product Picture of Sargramostim

Figure 11. Global Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type (2015-2020)

Figure 12. Global Neutropenia Biologic Drug Treatment Value Market Share by Drug Type (2015-2020)

Figure 13. Neutropenia Biologic Drug Treatment Consumed in Retail Pharmacies

Figure 14. Global Neutropenia Biologic Drug Treatment Market: Retail Pharmacies (2015-2020) (K Units)

Figure 15. Global Neutropenia Biologic Drug Treatment Market: Retail Pharmacies (2015-2020) ($ Millions)

Figure 16. Neutropenia Biologic Drug Treatment Consumed in Hospital Pharmacies

Figure 17. Global Neutropenia Biologic Drug Treatment Market: Hospital Pharmacies (2015-2020) (K Units)

Figure 18. Global Neutropenia Biologic Drug Treatment Market: Hospital Pharmacies (2015-2020) ($ Millions)

Figure 19. Neutropenia Biologic Drug Treatment Consumed in Online Pharmacies

Figure 20. Global Neutropenia Biologic Drug Treatment Market: Online Pharmacies (2015-2020) (K Units)

Figure 21. Global Neutropenia Biologic Drug Treatment Market: Online Pharmacies (2015-2020) ($ Millions)

Figure 22. Global Neutropenia Biologic Drug Treatment Consumption Market Share by Application (2015-2020)

Figure 23. Global Neutropenia Biologic Drug Treatment Value Market Share by Application (2015-2020)

Figure 24. Global Neutropenia Biologic Drug Treatment Sales Market Share by Company in 2017

Figure 25. Global Neutropenia Biologic Drug Treatment Sales Market Share by Company in 2019

Figure 26. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company in 2017

Figure 27. Global Neutropenia Biologic Drug Treatment Revenue Market Share by Company in 2019

Figure 28. Global Neutropenia Biologic Drug Treatment Sale Price by Company in 2019

Figure 29. Global Neutropenia Biologic Drug Treatment Consumption Market Share by Regions 2015-2020

Figure 30. Global Neutropenia Biologic Drug Treatment Value Market Share by Regions 2015-2020

Figure 31. Americas Neutropenia Biologic Drug Treatment Consumption 2015-2020 (K Units)

Figure 32. Americas Neutropenia Biologic Drug Treatment Value 2015-2020 ($ Millions)

Figure 33. APAC Neutropenia Biologic Drug Treatment Consumption 2015-2020 (K Units)

Figure 34. APAC Neutropenia Biologic Drug Treatment Value 2015-2020 ($ Millions)

Figure 35. Europe Neutropenia Biologic Drug Treatment Consumption 2015-2020 (K Units)

Figure 36. Europe Neutropenia Biologic Drug Treatment Value 2015-2020 ($ Millions)

Figure 37. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption 2015-2020 (K Units)

Figure 38. Middle East & Africa Neutropenia Biologic Drug Treatment Value 2015-2020 ($ Millions)

Figure 39. Americas Neutropenia Biologic Drug Treatment Consumption Market Share by Countries in 2019

Figure 40. Americas Neutropenia Biologic Drug Treatment Value Market Share by Countries in 2019

Figure 41. Americas Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type in 2019

Figure 42. Americas Neutropenia Biologic Drug Treatment Consumption Market Share by Application in 2019

Figure 43. United States Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 44. United States Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 45. Canada Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 46. Canada Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 47. Mexico Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 48. Mexico Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 49. APAC Neutropenia Biologic Drug Treatment Consumption Market Share by Countries in 2019

Figure 50. APAC Neutropenia Biologic Drug Treatment Value Market Share by Regions in 2019

Figure 51. APAC Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type in 2019

Figure 52. APAC Neutropenia Biologic Drug Treatment Consumption Market Share by Application in 2019

Figure 53. China Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 54. China Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 55. Japan Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 56. Japan Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 57. Korea Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 58. Korea Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 59. Southeast Asia Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 60. Southeast Asia Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 61. India Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 62. India Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 63. Australia Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 64. Australia Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 65. Europe Neutropenia Biologic Drug Treatment Consumption Market Share by Countries in 2019

Figure 66. Europe Neutropenia Biologic Drug Treatment Value Market Share by Countries in 2019

Figure 67. Europe Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type in 2019

Figure 68. Europe Neutropenia Biologic Drug Treatment Consumption Market Share by Application in 2019

Figure 69. Germany Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 70. Germany Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 71. France Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 72. France Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 73. UK Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 74. UK Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 75. Italy Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 76. Italy Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 77. Russia Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 78. Russia Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 79. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption Market Share by Countries in 2019

Figure 80. Middle East & Africa Neutropenia Biologic Drug Treatment Value Market Share by Countries in 2019

Figure 81. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption Market Share by Drug Type in 2019

Figure 82. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption Market Share by Application in 2019

Figure 83. Egypt Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 84. Egypt Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 85. South Africa Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 86. South Africa Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 87. Israel Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 88. Israel Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 89. Turkey Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 90. Turkey Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 91. GCC Countries Neutropenia Biologic Drug Treatment Consumption Growth 2015-2020 (K Units)

Figure 92. GCC Countries Neutropenia Biologic Drug Treatment Value Growth 2015-2020 ($ Millions)

Figure 93. Global Neutropenia Biologic Drug Treatment Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 94. Global Neutropenia Biologic Drug Treatment Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 95. Americas Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 96. Americas Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 97. APAC Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 98. APAC Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 99. Europe Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 100. Europe Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 101. Middle East & Africa Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 102. Middle East & Africa Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 103. United States Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 104. United States Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 105. Canada Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 106. Canada Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 107. Mexico Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 108. Mexico Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 109. Brazil Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 110. Brazil Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 111. China Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 112. China Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 113. Japan Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 114. Japan Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 115. Korea Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 116. Korea Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 117. Southeast Asia Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 118. Southeast Asia Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 119. India Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 120. India Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 121. Australia Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 122. Australia Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 123. Germany Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 124. Germany Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 125. France Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 126. France Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 127. UK Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 128. UK Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 129. Italy Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 130. Italy Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 131. Russia Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 132. Russia Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 133. Spain Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 134. Spain Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 135. Egypt Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 136. Egypt Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 137. South Africa Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 138. South Africa Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 139. Israel Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 140. Israel Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 141. Turkey Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 142. Turkey Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 143. GCC Countries Neutropenia Biologic Drug Treatment Consumption 2021-2025 (K Units)

Figure 144. GCC Countries Neutropenia Biologic Drug Treatment Value 2021-2025 ($ Millions)

Figure 145. Amgen Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 146. Kyowa Kirin Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 147. Novartis Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 148. Baxter International Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 149. Cellerant Therapeutics Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 150. Pfizer Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 151. Sanofi Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 152. Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 153. Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 154. Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 155. CVS Health Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 156. Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Market Share (2018-2020)

Figure 157. Partner Therapeutics Neutropenia Biologic Drug Treatment Market Share (2018-2020)